26 results
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Recommendations for Preventing ... areas Preferred Therapy ... #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
efficacy of this therapy ... Preferred Therapy ... #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Recommendations for Preventing ... Infections in HIV-AIDS Preventing ... #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Chronic Obstructive Pulmonary ... disease (COPD) ... escalation in therapy ... #Algorithm #Management ... SABA #SAMA #ICS #Pharmacology
Asthma Maintenance Therapy - Stepwise Approach 

Low dose ICS 
-> Low dose ICS/LABA or Med/High dose
Asthma Maintenance Therapy ... product used in COPD ... nonpharmacologic management ... #Management #Pharmacology ... #Pulmonary
COPD Management Algorithm - GOLD 2019 guidelines 

Categorize into COPD GOLD A-D -> Initiate first-line therapy
COPD Management ... Initiate first-line therapy ... GOLD2019 #Guidelines #Management ... #Pulmonary #Algorithm ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
days) Preferred Therapy ... mucosal #IDSA #Prevention ... #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
mm3 Preferred Therapy ... Leishmaniasis #Prevention ... #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
Infection General Management ... IsosporaBelli #IDSA #Prevention ... #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
Effusion Lymphoma (PEL ... as adjunctive therapy ... #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology